Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 3674946, 8 pages
http://dx.doi.org/10.1155/2016/3674946
Research Article

Lower Hemoglobin Concentration Is Associated with Retinal Ischemia and the Severity of Diabetic Retinopathy in Type 2 Diabetes

1Department of Ophthalmology, University Hospital Arnau de Vilanova, 25198 Lleida, Spain
2Department of Endocrinology and Nutrition, University Hospital Arnau de Vilanova, 25198 Lleida, Spain
3Institut de Recerca Biomedica de Lleida, University of Lleida, 25198 Lleida, Spain
4Department of Endocrinology and Nutrition, Institut d’Investigacions Biomediques August Pi Suñer, CIBER de Obesidad y Nutrición, Hospital Clinic, 08036 Barcelona, Spain
5Department of Optometry, University Hospital Arnau de Vilanova, 25198 Lleida, Spain
6Department of Endocrinology and Nutrition, CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Health Sciences Research Institute and University Hospital Germans Trias i Pujol, 08916 Badalona, Spain

Received 19 December 2015; Accepted 31 March 2016

Academic Editor: Marco Songini

Copyright © 2016 Alicia Traveset et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Whiting, L. Guariguata, C. Weil, and J. Shaw, “IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030,” Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Kahn, G. Weir, G. King et al., “Ocular complications of diabetes mellitus,” in Joslin's Diabetes Mellitus, vol. 901e21, LWW, Baltimore, Md, USA, 14th edition, 2005. View at Google Scholar
  3. M. García-Ramírez, C. Hernández, and R. Simó, “Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects,” Diabetes Care, vol. 31, no. 6, pp. 1189–1194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Simó, C. Hernández, and European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR), “Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives,” Trends in Endocrinology Metabolism, vol. 25, no. 21, pp. 23–33, 2014. View at Google Scholar
  5. C. Hernández, A. Fonollosa, M. García-Ramírez et al., “Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema,” Diabetes Care, vol. 29, no. 9, pp. 2028–2033, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Klein, B. E. K. Klein, and S. E. Moss, “The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years,” Archives of Ophthalmology, vol. 102, no. 4, pp. 520–526, 1984. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Kohner, S. J. Aldington, I. M. Stratton et al., “United kingdom prospective diabetes study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors,” Archives of Ophthalmology, vol. 116, no. 3, pp. 297–303, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. I. M. Stratton, E. M. Kohner, S. J. Aldington et al., “UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis,” Diabetologia, vol. 44, no. 2, pp. 156–163, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. I. M. Stratton, A. I. Adler, H. A. W. Neil et al., “Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study,” British Medical Journal, vol. 321, no. 7258, pp. 405–412, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. B. He, L. Wei, Y. Gu et al., “Factors associated with diabetic retinopathy in chinese patients with type 2 diabetes mellitus,” International Journal of Endocrinology, vol. 2012, Article ID 157940, 8 pages, 2012. View at Publisher · View at Google Scholar
  11. R. Karoli, J. Fatima, V. Shukla, P. Garg, and A. Ali, “Predictors of diabetic retinopathy in patients with type 2 diabetes who have normoalbuminuria,” Annals of Medical and Health Sciences Research, vol. 3, no. 4, pp. 536–540, 2013. View at Publisher · View at Google Scholar
  12. M. D. Davis, M. R. Fisher, R. E. Gangnon et al., “Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report 18,” Investigative Ophthalmology and Visual Science, vol. 39, no. 2, pp. 233–252, 1998. View at Google Scholar · View at Scopus
  13. Q. Qiao, S. Keinänen-Kiukaanniemi, and E. Läärä, “The relationship between hemoglobin levels and diabetic retinopathy,” Journal of Clinical Epidemiology, vol. 50, no. 2, pp. 153–158, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. V. K. Ajoy Mohan, S. Nithyanandam, and J. Idiculla, “Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy,” Indian Journal of Ophthalmology, vol. 59, no. 3, pp. 207–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Irace, F. Scarinci, V. Scorcia et al., “Association among low whole blood viscosity, haematocrit, haemoglobin and diabetic retinopathy in subjects with type 2 diabetes,” British Journal of Ophthalmology, vol. 95, no. 1, pp. 94–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Bahar, Z. Kashi, A. A. Amiri, and M. Nabipour, “Association between diabetic retinopathy and hemoglobin level,” Caspian Journal of Internal Medicine, vol. 4, no. 4, pp. 759–762, 2013. View at Google Scholar · View at Scopus
  17. P. K. Rani, R. Raman, S. R. Rachepalli et al., “Anemia and diabetic retinopathy in type 2 diabetes mellitus,” Journal of Association of Physicians of India, vol. 58, no. 2, pp. 91–94, 2010. View at Google Scholar · View at Scopus
  18. E. A. Friedman, C. D. Brown, and D. H. Berman, “Erythropoietin in diabetic macular edema and renal insufficiency,” American Journal of Kidney Diseases, vol. 26, no. 1, pp. 202–208, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Singh, V. Gupta, A. Gupta et al., “Spontaneous closure of micro-aneurysms in diabetic retinopathy with treatment of co-existing anemia,” British Journal of Ophthalmology, vol. 89, no. 2, pp. 248–249, 2005. View at Google Scholar
  20. N. Alonso, A. Traveset, E. Rubinat et al., “Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy,” Cardiovascular Diabetology, vol. 14, no. 1, article 33, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. C. P. Wilkinson, F. L. Ferris III, R. E. Klein et al., “Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales,” Ophthalmology, vol. 110, no. 9, pp. 1677–1682, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Kinyoun, F. Barton, M. Fisher et al., “Detection of diabetic macular edema. Ophthalmoscopy versus photography—early treatment diabetic retinopathy study report number 5,” Ophthalmology, vol. 96, no. 6, pp. 746–751, 1989. View at Publisher · View at Google Scholar · View at Scopus
  23. S. J. Aldington, E. M. Kohner, S. Meuer et al., “Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study,” Diabetologia, vol. 38, no. 4, pp. 437–444, 1995. View at Publisher · View at Google Scholar
  24. Early Treatment Diabetic Retinopathy Study Research Group, “Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11,” Ophthalmology, vol. 98, no. 5, supplement, pp. 807–822, 1991. View at Publisher · View at Google Scholar
  25. M. DeNiro and F. A. Al-Mohanna, “Erythropoietin and anemia: biological markers that cannot be ignored in diabetic retinopathy,” Medical Hypotheses, vol. 78, no. 4, pp. 555–556, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. R. Shorb, “Anemia and diabetic retinopathy,” American Journal of Ophthalmology, vol. 100, no. 3, pp. 434–436, 1985. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Barnes, P. Locke, P. R. Scudder, T. L. Dormandy, J. A. Dormandy, and J. Slack, “Is hyperviscosity a treatable component of diabetic microcirculatory disease?” The Lancet, vol. 310, no. 8042, pp. 789–791, 1977. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Schmid-Schönbein and E. Volger, “Red-cell aggregation and red-cell deformability in diabetes,” Diabetes, vol. 25, supplement 2, pp. 897–902, 1976. View at Google Scholar
  29. D. E. McMillan, N. G. Utterback, and J. La Puma, “Reduced erythrocyte deformability in diabetes,” Diabetes, vol. 27, no. 9, pp. 895–901, 1978. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Goldstein, I. Leibovitch, S. Levin et al., “Red blood cell membrane mechanical fluctuations in non-proliferative and proliferate diabetic retinopathy,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 242, no. 11, pp. 937–943, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. O. M. Jew, M. Peyman, T. C. Chen, and S. Visvaraja, “Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes,” International Journal of Ophthalmology, vol. 5, no. 4, pp. 499–504, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. T. M. Diep and I. Tsui, “Risk factors associated with diabetic macular edema,” Diabetes Research and Clinical Practice, vol. 100, no. 3, pp. 298–305, 2013. View at Publisher · View at Google Scholar · View at Scopus